Talphera Inc
Follow $TLPH
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $TLPH by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is TLPH moving today?
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
TLPH overview
Related filings and maps
Congress activity in TLPH
No receipt-qualified Congressional disclosure is present for TLPH in the cached public ledger.
TLPH contract awards, year to date.
Public federal awards linked to this ticker.
TLPH lobbying filings, year to date.
Registered lobbying filings matched to Talphera Inc.